nodes	percent_of_prediction	percent_of_DWPC	metapath
Atazanavir—ABCB1—ovarian cancer	0.276	1	CbGaD
Atazanavir—SLCO1B3—Paclitaxel—ovarian cancer	0.0997	0.176	CbGbCtD
Atazanavir—SLCO1B3—Docetaxel—ovarian cancer	0.0721	0.127	CbGbCtD
Atazanavir—ABCC1—Epirubicin—ovarian cancer	0.0699	0.123	CbGbCtD
Atazanavir—ABCC1—Paclitaxel—ovarian cancer	0.0689	0.122	CbGbCtD
Atazanavir—ABCC1—Docetaxel—ovarian cancer	0.0498	0.088	CbGbCtD
Atazanavir—ABCC1—Doxorubicin—ovarian cancer	0.0372	0.0656	CbGbCtD
Atazanavir—ABCB1—Topotecan—ovarian cancer	0.0336	0.0593	CbGbCtD
Atazanavir—ABCB1—Vinorelbine—ovarian cancer	0.0237	0.0418	CbGbCtD
Atazanavir—CYP3A4—Topotecan—ovarian cancer	0.0201	0.0355	CbGbCtD
Atazanavir—CYP2C9—Paclitaxel—ovarian cancer	0.0171	0.0303	CbGbCtD
Atazanavir—ABCB1—Paclitaxel—ovarian cancer	0.0166	0.0294	CbGbCtD
Atazanavir—CYP3A4—Vinorelbine—ovarian cancer	0.0142	0.025	CbGbCtD
Atazanavir—ABCB1—Docetaxel—ovarian cancer	0.012	0.0212	CbGbCtD
Atazanavir—CYP3A4—Paclitaxel—ovarian cancer	0.00997	0.0176	CbGbCtD
Atazanavir—ABCB1—Doxorubicin—ovarian cancer	0.00896	0.0158	CbGbCtD
Atazanavir—CYP3A4—Docetaxel—ovarian cancer	0.00721	0.0127	CbGbCtD
Atazanavir—CYP3A4—Doxorubicin—ovarian cancer	0.00537	0.00948	CbGbCtD
Atazanavir—Lopinavir—ABCB1—ovarian cancer	0.000561	0.404	CrCbGaD
Atazanavir—Ritonavir—ABCB1—ovarian cancer	0.000471	0.339	CrCbGaD
Atazanavir—Saquinavir—ABCB1—ovarian cancer	0.000357	0.257	CrCbGaD
Atazanavir—Nasopharyngitis—Doxorubicin—ovarian cancer	0.000119	0.000762	CcSEcCtD
Atazanavir—Anorexia—Paclitaxel—ovarian cancer	0.000118	0.000755	CcSEcCtD
Atazanavir—Gastritis—Doxorubicin—ovarian cancer	0.000118	0.000755	CcSEcCtD
Atazanavir—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000117	0.000752	CcSEcCtD
Atazanavir—Muscular weakness—Doxorubicin—ovarian cancer	0.000117	0.000752	CcSEcCtD
Atazanavir—Vomiting—Vinorelbine—ovarian cancer	0.000117	0.000749	CcSEcCtD
Atazanavir—Neutropenia—Epirubicin—ovarian cancer	0.000116	0.000745	CcSEcCtD
Atazanavir—Rash—Vinorelbine—ovarian cancer	0.000116	0.000743	CcSEcCtD
Atazanavir—Dermatitis—Vinorelbine—ovarian cancer	0.000116	0.000742	CcSEcCtD
Atazanavir—Abdominal distension—Doxorubicin—ovarian cancer	0.000116	0.000742	CcSEcCtD
Atazanavir—Headache—Vinorelbine—ovarian cancer	0.000115	0.000738	CcSEcCtD
Atazanavir—Syncope—Docetaxel—ovarian cancer	0.000115	0.000738	CcSEcCtD
Atazanavir—Pollakiuria—Epirubicin—ovarian cancer	0.000115	0.000736	CcSEcCtD
Atazanavir—Eosinophilia—Doxorubicin—ovarian cancer	0.000114	0.00073	CcSEcCtD
Atazanavir—Palpitations—Docetaxel—ovarian cancer	0.000114	0.000727	CcSEcCtD
Atazanavir—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000113	0.000727	CcSEcCtD
Atazanavir—Weight increased—Epirubicin—ovarian cancer	0.000113	0.000725	CcSEcCtD
Atazanavir—Loss of consciousness—Docetaxel—ovarian cancer	0.000113	0.000723	CcSEcCtD
Atazanavir—Pancreatitis—Doxorubicin—ovarian cancer	0.000113	0.000722	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000113	0.000722	CcSEcCtD
Atazanavir—Weight decreased—Epirubicin—ovarian cancer	0.000112	0.000721	CcSEcCtD
Atazanavir—Hyperglycaemia—Epirubicin—ovarian cancer	0.000112	0.000718	CcSEcCtD
Atazanavir—Cough—Docetaxel—ovarian cancer	0.000112	0.000718	CcSEcCtD
Atazanavir—Insomnia—Paclitaxel—ovarian cancer	0.000112	0.000716	CcSEcCtD
Atazanavir—Convulsion—Docetaxel—ovarian cancer	0.000111	0.000713	CcSEcCtD
Atazanavir—Hypertension—Docetaxel—ovarian cancer	0.000111	0.00071	CcSEcCtD
Atazanavir—Dyspnoea—Paclitaxel—ovarian cancer	0.00011	0.000706	CcSEcCtD
Atazanavir—Somnolence—Paclitaxel—ovarian cancer	0.00011	0.000704	CcSEcCtD
Atazanavir—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.00011	0.000704	CcSEcCtD
Atazanavir—Chest pain—Docetaxel—ovarian cancer	0.000109	0.0007	CcSEcCtD
Atazanavir—Myalgia—Docetaxel—ovarian cancer	0.000109	0.0007	CcSEcCtD
Atazanavir—Arthralgia—Docetaxel—ovarian cancer	0.000109	0.0007	CcSEcCtD
Atazanavir—Nausea—Vinorelbine—ovarian cancer	0.000109	0.0007	CcSEcCtD
Atazanavir—Renal failure—Epirubicin—ovarian cancer	0.000109	0.000698	CcSEcCtD
Atazanavir—Dyspepsia—Paclitaxel—ovarian cancer	0.000109	0.000697	CcSEcCtD
Atazanavir—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000109	0.000696	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000109	0.000696	CcSEcCtD
Atazanavir—Jaundice—Epirubicin—ovarian cancer	0.000108	0.000692	CcSEcCtD
Atazanavir—Stomatitis—Epirubicin—ovarian cancer	0.000108	0.000692	CcSEcCtD
Atazanavir—Urinary tract infection—Epirubicin—ovarian cancer	0.000108	0.00069	CcSEcCtD
Atazanavir—Neutropenia—Doxorubicin—ovarian cancer	0.000108	0.000689	CcSEcCtD
Atazanavir—Decreased appetite—Paclitaxel—ovarian cancer	0.000108	0.000689	CcSEcCtD
Atazanavir—Dry mouth—Docetaxel—ovarian cancer	0.000107	0.000685	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000107	0.000684	CcSEcCtD
Atazanavir—Fatigue—Paclitaxel—ovarian cancer	0.000107	0.000683	CcSEcCtD
Atazanavir—Sweating—Epirubicin—ovarian cancer	0.000106	0.000681	CcSEcCtD
Atazanavir—Pollakiuria—Doxorubicin—ovarian cancer	0.000106	0.000681	CcSEcCtD
Atazanavir—Pain—Paclitaxel—ovarian cancer	0.000106	0.000677	CcSEcCtD
Atazanavir—Constipation—Paclitaxel—ovarian cancer	0.000106	0.000677	CcSEcCtD
Atazanavir—Haematuria—Epirubicin—ovarian cancer	0.000106	0.000677	CcSEcCtD
Atazanavir—Confusional state—Docetaxel—ovarian cancer	0.000106	0.000677	CcSEcCtD
Atazanavir—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000105	0.000673	CcSEcCtD
Atazanavir—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000105	0.000672	CcSEcCtD
Atazanavir—Oedema—Docetaxel—ovarian cancer	0.000105	0.000671	CcSEcCtD
Atazanavir—Weight increased—Doxorubicin—ovarian cancer	0.000105	0.000671	CcSEcCtD
Atazanavir—Infection—Docetaxel—ovarian cancer	0.000104	0.000667	CcSEcCtD
Atazanavir—Weight decreased—Doxorubicin—ovarian cancer	0.000104	0.000667	CcSEcCtD
Atazanavir—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000104	0.000665	CcSEcCtD
Atazanavir—Shock—Docetaxel—ovarian cancer	0.000103	0.000661	CcSEcCtD
Atazanavir—Nervous system disorder—Docetaxel—ovarian cancer	0.000103	0.000658	CcSEcCtD
Atazanavir—Feeling abnormal—Paclitaxel—ovarian cancer	0.000102	0.000653	CcSEcCtD
Atazanavir—Skin disorder—Docetaxel—ovarian cancer	0.000102	0.000652	CcSEcCtD
Atazanavir—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000102	0.000651	CcSEcCtD
Atazanavir—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000101	0.000648	CcSEcCtD
Atazanavir—Renal failure—Doxorubicin—ovarian cancer	0.000101	0.000646	CcSEcCtD
Atazanavir—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000101	0.000644	CcSEcCtD
Atazanavir—Jaundice—Doxorubicin—ovarian cancer	0.0001	0.00064	CcSEcCtD
Atazanavir—Stomatitis—Doxorubicin—ovarian cancer	0.0001	0.00064	CcSEcCtD
Atazanavir—Anorexia—Docetaxel—ovarian cancer	9.99e-05	0.00064	CcSEcCtD
Atazanavir—Urinary tract infection—Doxorubicin—ovarian cancer	9.97e-05	0.000639	CcSEcCtD
Atazanavir—Hepatitis—Epirubicin—ovarian cancer	9.95e-05	0.000637	CcSEcCtD
Atazanavir—Hypoaesthesia—Epirubicin—ovarian cancer	9.9e-05	0.000634	CcSEcCtD
Atazanavir—Sweating—Doxorubicin—ovarian cancer	9.83e-05	0.00063	CcSEcCtD
Atazanavir—Urinary tract disorder—Epirubicin—ovarian cancer	9.83e-05	0.00063	CcSEcCtD
Atazanavir—Urticaria—Paclitaxel—ovarian cancer	9.82e-05	0.000629	CcSEcCtD
Atazanavir—Oedema peripheral—Epirubicin—ovarian cancer	9.8e-05	0.000628	CcSEcCtD
Atazanavir—Haematuria—Doxorubicin—ovarian cancer	9.78e-05	0.000626	CcSEcCtD
Atazanavir—Connective tissue disorder—Epirubicin—ovarian cancer	9.78e-05	0.000626	CcSEcCtD
Atazanavir—Body temperature increased—Paclitaxel—ovarian cancer	9.78e-05	0.000626	CcSEcCtD
Atazanavir—Abdominal pain—Paclitaxel—ovarian cancer	9.78e-05	0.000626	CcSEcCtD
Atazanavir—Urethral disorder—Epirubicin—ovarian cancer	9.76e-05	0.000625	CcSEcCtD
Atazanavir—Hepatobiliary disease—Doxorubicin—ovarian cancer	9.7e-05	0.000621	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Docetaxel—ovarian cancer	9.55e-05	0.000612	CcSEcCtD
Atazanavir—Insomnia—Docetaxel—ovarian cancer	9.48e-05	0.000607	CcSEcCtD
Atazanavir—Erythema multiforme—Epirubicin—ovarian cancer	9.41e-05	0.000603	CcSEcCtD
Atazanavir—Dyspnoea—Docetaxel—ovarian cancer	9.35e-05	0.000599	CcSEcCtD
Atazanavir—Somnolence—Docetaxel—ovarian cancer	9.32e-05	0.000597	CcSEcCtD
Atazanavir—Eye disorder—Epirubicin—ovarian cancer	9.3e-05	0.000596	CcSEcCtD
Atazanavir—Tinnitus—Epirubicin—ovarian cancer	9.28e-05	0.000594	CcSEcCtD
Atazanavir—Cardiac disorder—Epirubicin—ovarian cancer	9.24e-05	0.000592	CcSEcCtD
Atazanavir—Dyspepsia—Docetaxel—ovarian cancer	9.23e-05	0.000591	CcSEcCtD
Atazanavir—Hepatitis—Doxorubicin—ovarian cancer	9.21e-05	0.00059	CcSEcCtD
Atazanavir—Hypoaesthesia—Doxorubicin—ovarian cancer	9.16e-05	0.000587	CcSEcCtD
Atazanavir—Decreased appetite—Docetaxel—ovarian cancer	9.11e-05	0.000584	CcSEcCtD
Atazanavir—Hypersensitivity—Paclitaxel—ovarian cancer	9.11e-05	0.000584	CcSEcCtD
Atazanavir—Urinary tract disorder—Doxorubicin—ovarian cancer	9.09e-05	0.000582	CcSEcCtD
Atazanavir—Oedema peripheral—Doxorubicin—ovarian cancer	9.07e-05	0.000581	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Docetaxel—ovarian cancer	9.05e-05	0.00058	CcSEcCtD
Atazanavir—Connective tissue disorder—Doxorubicin—ovarian cancer	9.05e-05	0.00058	CcSEcCtD
Atazanavir—Fatigue—Docetaxel—ovarian cancer	9.04e-05	0.000579	CcSEcCtD
Atazanavir—Angiopathy—Epirubicin—ovarian cancer	9.03e-05	0.000578	CcSEcCtD
Atazanavir—Urethral disorder—Doxorubicin—ovarian cancer	9.03e-05	0.000578	CcSEcCtD
Atazanavir—Immune system disorder—Epirubicin—ovarian cancer	8.99e-05	0.000576	CcSEcCtD
Atazanavir—Mediastinal disorder—Epirubicin—ovarian cancer	8.97e-05	0.000575	CcSEcCtD
Atazanavir—Constipation—Docetaxel—ovarian cancer	8.96e-05	0.000574	CcSEcCtD
Atazanavir—Pain—Docetaxel—ovarian cancer	8.96e-05	0.000574	CcSEcCtD
Atazanavir—Asthenia—Paclitaxel—ovarian cancer	8.87e-05	0.000568	CcSEcCtD
Atazanavir—Alopecia—Epirubicin—ovarian cancer	8.79e-05	0.000563	CcSEcCtD
Atazanavir—Pruritus—Paclitaxel—ovarian cancer	8.75e-05	0.00056	CcSEcCtD
Atazanavir—Mental disorder—Epirubicin—ovarian cancer	8.72e-05	0.000558	CcSEcCtD
Atazanavir—Erythema multiforme—Doxorubicin—ovarian cancer	8.71e-05	0.000558	CcSEcCtD
Atazanavir—Malnutrition—Epirubicin—ovarian cancer	8.66e-05	0.000555	CcSEcCtD
Atazanavir—Feeling abnormal—Docetaxel—ovarian cancer	8.64e-05	0.000553	CcSEcCtD
Atazanavir—Eye disorder—Doxorubicin—ovarian cancer	8.61e-05	0.000551	CcSEcCtD
Atazanavir—Tinnitus—Doxorubicin—ovarian cancer	8.59e-05	0.00055	CcSEcCtD
Atazanavir—Gastrointestinal pain—Docetaxel—ovarian cancer	8.57e-05	0.000549	CcSEcCtD
Atazanavir—Cardiac disorder—Doxorubicin—ovarian cancer	8.55e-05	0.000547	CcSEcCtD
Atazanavir—Flatulence—Epirubicin—ovarian cancer	8.54e-05	0.000547	CcSEcCtD
Atazanavir—Tension—Epirubicin—ovarian cancer	8.5e-05	0.000545	CcSEcCtD
Atazanavir—Dysgeusia—Epirubicin—ovarian cancer	8.48e-05	0.000543	CcSEcCtD
Atazanavir—Diarrhoea—Paclitaxel—ovarian cancer	8.46e-05	0.000542	CcSEcCtD
Atazanavir—Nervousness—Epirubicin—ovarian cancer	8.41e-05	0.000539	CcSEcCtD
Atazanavir—Back pain—Epirubicin—ovarian cancer	8.38e-05	0.000537	CcSEcCtD
Atazanavir—Angiopathy—Doxorubicin—ovarian cancer	8.35e-05	0.000535	CcSEcCtD
Atazanavir—Immune system disorder—Doxorubicin—ovarian cancer	8.32e-05	0.000533	CcSEcCtD
Atazanavir—Mediastinal disorder—Doxorubicin—ovarian cancer	8.3e-05	0.000532	CcSEcCtD
Atazanavir—Abdominal pain—Docetaxel—ovarian cancer	8.29e-05	0.000531	CcSEcCtD
Atazanavir—Body temperature increased—Docetaxel—ovarian cancer	8.29e-05	0.000531	CcSEcCtD
Atazanavir—Dizziness—Paclitaxel—ovarian cancer	8.18e-05	0.000524	CcSEcCtD
Atazanavir—Alopecia—Doxorubicin—ovarian cancer	8.14e-05	0.000521	CcSEcCtD
Atazanavir—Mental disorder—Doxorubicin—ovarian cancer	8.07e-05	0.000517	CcSEcCtD
Atazanavir—Ill-defined disorder—Epirubicin—ovarian cancer	8.04e-05	0.000515	CcSEcCtD
Atazanavir—Malnutrition—Doxorubicin—ovarian cancer	8.02e-05	0.000513	CcSEcCtD
Atazanavir—Agitation—Epirubicin—ovarian cancer	7.96e-05	0.00051	CcSEcCtD
Atazanavir—Flatulence—Doxorubicin—ovarian cancer	7.9e-05	0.000506	CcSEcCtD
Atazanavir—Tension—Doxorubicin—ovarian cancer	7.87e-05	0.000504	CcSEcCtD
Atazanavir—Vomiting—Paclitaxel—ovarian cancer	7.86e-05	0.000504	CcSEcCtD
Atazanavir—Dysgeusia—Doxorubicin—ovarian cancer	7.85e-05	0.000503	CcSEcCtD
Atazanavir—Malaise—Epirubicin—ovarian cancer	7.81e-05	0.0005	CcSEcCtD
Atazanavir—Rash—Paclitaxel—ovarian cancer	7.8e-05	0.000499	CcSEcCtD
Atazanavir—Dermatitis—Paclitaxel—ovarian cancer	7.79e-05	0.000499	CcSEcCtD
Atazanavir—Nervousness—Doxorubicin—ovarian cancer	7.79e-05	0.000499	CcSEcCtD
Atazanavir—Syncope—Epirubicin—ovarian cancer	7.77e-05	0.000498	CcSEcCtD
Atazanavir—Back pain—Doxorubicin—ovarian cancer	7.75e-05	0.000497	CcSEcCtD
Atazanavir—Headache—Paclitaxel—ovarian cancer	7.75e-05	0.000496	CcSEcCtD
Atazanavir—Hypersensitivity—Docetaxel—ovarian cancer	7.72e-05	0.000495	CcSEcCtD
Atazanavir—Palpitations—Epirubicin—ovarian cancer	7.66e-05	0.00049	CcSEcCtD
Atazanavir—Loss of consciousness—Epirubicin—ovarian cancer	7.61e-05	0.000488	CcSEcCtD
Atazanavir—Cough—Epirubicin—ovarian cancer	7.56e-05	0.000484	CcSEcCtD
Atazanavir—Asthenia—Docetaxel—ovarian cancer	7.52e-05	0.000482	CcSEcCtD
Atazanavir—Convulsion—Epirubicin—ovarian cancer	7.51e-05	0.000481	CcSEcCtD
Atazanavir—Hypertension—Epirubicin—ovarian cancer	7.48e-05	0.000479	CcSEcCtD
Atazanavir—Ill-defined disorder—Doxorubicin—ovarian cancer	7.44e-05	0.000476	CcSEcCtD
Atazanavir—Pruritus—Docetaxel—ovarian cancer	7.42e-05	0.000475	CcSEcCtD
Atazanavir—Myalgia—Epirubicin—ovarian cancer	7.38e-05	0.000472	CcSEcCtD
Atazanavir—Arthralgia—Epirubicin—ovarian cancer	7.38e-05	0.000472	CcSEcCtD
Atazanavir—Chest pain—Epirubicin—ovarian cancer	7.38e-05	0.000472	CcSEcCtD
Atazanavir—Agitation—Doxorubicin—ovarian cancer	7.37e-05	0.000472	CcSEcCtD
Atazanavir—Anxiety—Epirubicin—ovarian cancer	7.35e-05	0.000471	CcSEcCtD
Atazanavir—Nausea—Paclitaxel—ovarian cancer	7.35e-05	0.000471	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	7.32e-05	0.000469	CcSEcCtD
Atazanavir—Discomfort—Epirubicin—ovarian cancer	7.29e-05	0.000467	CcSEcCtD
Atazanavir—Malaise—Doxorubicin—ovarian cancer	7.23e-05	0.000463	CcSEcCtD
Atazanavir—Dry mouth—Epirubicin—ovarian cancer	7.21e-05	0.000462	CcSEcCtD
Atazanavir—Syncope—Doxorubicin—ovarian cancer	7.19e-05	0.00046	CcSEcCtD
Atazanavir—Diarrhoea—Docetaxel—ovarian cancer	7.17e-05	0.000459	CcSEcCtD
Atazanavir—Confusional state—Epirubicin—ovarian cancer	7.13e-05	0.000457	CcSEcCtD
Atazanavir—Palpitations—Doxorubicin—ovarian cancer	7.08e-05	0.000454	CcSEcCtD
Atazanavir—Oedema—Epirubicin—ovarian cancer	7.07e-05	0.000453	CcSEcCtD
Atazanavir—Loss of consciousness—Doxorubicin—ovarian cancer	7.05e-05	0.000451	CcSEcCtD
Atazanavir—Infection—Epirubicin—ovarian cancer	7.02e-05	0.00045	CcSEcCtD
Atazanavir—Cough—Doxorubicin—ovarian cancer	6.99e-05	0.000448	CcSEcCtD
Atazanavir—Shock—Epirubicin—ovarian cancer	6.96e-05	0.000446	CcSEcCtD
Atazanavir—Convulsion—Doxorubicin—ovarian cancer	6.94e-05	0.000445	CcSEcCtD
Atazanavir—Nervous system disorder—Epirubicin—ovarian cancer	6.93e-05	0.000444	CcSEcCtD
Atazanavir—Dizziness—Docetaxel—ovarian cancer	6.93e-05	0.000444	CcSEcCtD
Atazanavir—Hypertension—Doxorubicin—ovarian cancer	6.92e-05	0.000443	CcSEcCtD
Atazanavir—Skin disorder—Epirubicin—ovarian cancer	6.87e-05	0.00044	CcSEcCtD
Atazanavir—Hyperhidrosis—Epirubicin—ovarian cancer	6.83e-05	0.000438	CcSEcCtD
Atazanavir—Myalgia—Doxorubicin—ovarian cancer	6.82e-05	0.000437	CcSEcCtD
Atazanavir—Arthralgia—Doxorubicin—ovarian cancer	6.82e-05	0.000437	CcSEcCtD
Atazanavir—Chest pain—Doxorubicin—ovarian cancer	6.82e-05	0.000437	CcSEcCtD
Atazanavir—Anxiety—Doxorubicin—ovarian cancer	6.8e-05	0.000436	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	6.78e-05	0.000434	CcSEcCtD
Atazanavir—Discomfort—Doxorubicin—ovarian cancer	6.74e-05	0.000432	CcSEcCtD
Atazanavir—Anorexia—Epirubicin—ovarian cancer	6.74e-05	0.000432	CcSEcCtD
Atazanavir—Dry mouth—Doxorubicin—ovarian cancer	6.67e-05	0.000428	CcSEcCtD
Atazanavir—Vomiting—Docetaxel—ovarian cancer	6.66e-05	0.000427	CcSEcCtD
Atazanavir—Rash—Docetaxel—ovarian cancer	6.61e-05	0.000423	CcSEcCtD
Atazanavir—Dermatitis—Docetaxel—ovarian cancer	6.6e-05	0.000423	CcSEcCtD
Atazanavir—Confusional state—Doxorubicin—ovarian cancer	6.6e-05	0.000423	CcSEcCtD
Atazanavir—Headache—Docetaxel—ovarian cancer	6.57e-05	0.000421	CcSEcCtD
Atazanavir—Oedema—Doxorubicin—ovarian cancer	6.54e-05	0.000419	CcSEcCtD
Atazanavir—Infection—Doxorubicin—ovarian cancer	6.5e-05	0.000416	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Epirubicin—ovarian cancer	6.44e-05	0.000413	CcSEcCtD
Atazanavir—Shock—Doxorubicin—ovarian cancer	6.44e-05	0.000412	CcSEcCtD
Atazanavir—Nervous system disorder—Doxorubicin—ovarian cancer	6.42e-05	0.000411	CcSEcCtD
Atazanavir—Insomnia—Epirubicin—ovarian cancer	6.39e-05	0.00041	CcSEcCtD
Atazanavir—Skin disorder—Doxorubicin—ovarian cancer	6.35e-05	0.000407	CcSEcCtD
Atazanavir—Hyperhidrosis—Doxorubicin—ovarian cancer	6.32e-05	0.000405	CcSEcCtD
Atazanavir—Dyspnoea—Epirubicin—ovarian cancer	6.3e-05	0.000404	CcSEcCtD
Atazanavir—Somnolence—Epirubicin—ovarian cancer	6.29e-05	0.000403	CcSEcCtD
Atazanavir—Anorexia—Doxorubicin—ovarian cancer	6.24e-05	0.000399	CcSEcCtD
Atazanavir—Nausea—Docetaxel—ovarian cancer	6.23e-05	0.000399	CcSEcCtD
Atazanavir—Dyspepsia—Epirubicin—ovarian cancer	6.22e-05	0.000399	CcSEcCtD
Atazanavir—Decreased appetite—Epirubicin—ovarian cancer	6.15e-05	0.000394	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Epirubicin—ovarian cancer	6.1e-05	0.000391	CcSEcCtD
Atazanavir—Fatigue—Epirubicin—ovarian cancer	6.1e-05	0.00039	CcSEcCtD
Atazanavir—Pain—Epirubicin—ovarian cancer	6.05e-05	0.000387	CcSEcCtD
Atazanavir—Constipation—Epirubicin—ovarian cancer	6.05e-05	0.000387	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	5.96e-05	0.000382	CcSEcCtD
Atazanavir—Insomnia—Doxorubicin—ovarian cancer	5.92e-05	0.000379	CcSEcCtD
Atazanavir—Dyspnoea—Doxorubicin—ovarian cancer	5.83e-05	0.000374	CcSEcCtD
Atazanavir—Feeling abnormal—Epirubicin—ovarian cancer	5.83e-05	0.000373	CcSEcCtD
Atazanavir—Somnolence—Doxorubicin—ovarian cancer	5.82e-05	0.000373	CcSEcCtD
Atazanavir—Gastrointestinal pain—Epirubicin—ovarian cancer	5.78e-05	0.00037	CcSEcCtD
Atazanavir—Dyspepsia—Doxorubicin—ovarian cancer	5.76e-05	0.000369	CcSEcCtD
Atazanavir—Decreased appetite—Doxorubicin—ovarian cancer	5.69e-05	0.000364	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Doxorubicin—ovarian cancer	5.65e-05	0.000362	CcSEcCtD
Atazanavir—Fatigue—Doxorubicin—ovarian cancer	5.64e-05	0.000361	CcSEcCtD
Atazanavir—Urticaria—Epirubicin—ovarian cancer	5.62e-05	0.00036	CcSEcCtD
Atazanavir—Pain—Doxorubicin—ovarian cancer	5.59e-05	0.000358	CcSEcCtD
Atazanavir—Constipation—Doxorubicin—ovarian cancer	5.59e-05	0.000358	CcSEcCtD
Atazanavir—Abdominal pain—Epirubicin—ovarian cancer	5.59e-05	0.000358	CcSEcCtD
Atazanavir—Body temperature increased—Epirubicin—ovarian cancer	5.59e-05	0.000358	CcSEcCtD
Atazanavir—Feeling abnormal—Doxorubicin—ovarian cancer	5.39e-05	0.000345	CcSEcCtD
Atazanavir—Gastrointestinal pain—Doxorubicin—ovarian cancer	5.35e-05	0.000343	CcSEcCtD
Atazanavir—Hypersensitivity—Epirubicin—ovarian cancer	5.21e-05	0.000334	CcSEcCtD
Atazanavir—Urticaria—Doxorubicin—ovarian cancer	5.2e-05	0.000333	CcSEcCtD
Atazanavir—Body temperature increased—Doxorubicin—ovarian cancer	5.17e-05	0.000331	CcSEcCtD
Atazanavir—Abdominal pain—Doxorubicin—ovarian cancer	5.17e-05	0.000331	CcSEcCtD
Atazanavir—Asthenia—Epirubicin—ovarian cancer	5.07e-05	0.000325	CcSEcCtD
Atazanavir—Pruritus—Epirubicin—ovarian cancer	5e-05	0.00032	CcSEcCtD
Atazanavir—Diarrhoea—Epirubicin—ovarian cancer	4.84e-05	0.00031	CcSEcCtD
Atazanavir—Hypersensitivity—Doxorubicin—ovarian cancer	4.82e-05	0.000309	CcSEcCtD
Atazanavir—Asthenia—Doxorubicin—ovarian cancer	4.69e-05	0.000301	CcSEcCtD
Atazanavir—Dizziness—Epirubicin—ovarian cancer	4.68e-05	0.000299	CcSEcCtD
Atazanavir—Pruritus—Doxorubicin—ovarian cancer	4.63e-05	0.000296	CcSEcCtD
Atazanavir—Vomiting—Epirubicin—ovarian cancer	4.5e-05	0.000288	CcSEcCtD
Atazanavir—Diarrhoea—Doxorubicin—ovarian cancer	4.48e-05	0.000287	CcSEcCtD
Atazanavir—Rash—Epirubicin—ovarian cancer	4.46e-05	0.000286	CcSEcCtD
Atazanavir—Dermatitis—Epirubicin—ovarian cancer	4.45e-05	0.000285	CcSEcCtD
Atazanavir—Headache—Epirubicin—ovarian cancer	4.43e-05	0.000284	CcSEcCtD
Atazanavir—Dizziness—Doxorubicin—ovarian cancer	4.33e-05	0.000277	CcSEcCtD
Atazanavir—Nausea—Epirubicin—ovarian cancer	4.2e-05	0.000269	CcSEcCtD
Atazanavir—Vomiting—Doxorubicin—ovarian cancer	4.16e-05	0.000266	CcSEcCtD
Atazanavir—Rash—Doxorubicin—ovarian cancer	4.12e-05	0.000264	CcSEcCtD
Atazanavir—Dermatitis—Doxorubicin—ovarian cancer	4.12e-05	0.000264	CcSEcCtD
Atazanavir—Headache—Doxorubicin—ovarian cancer	4.1e-05	0.000263	CcSEcCtD
Atazanavir—Nausea—Doxorubicin—ovarian cancer	3.89e-05	0.000249	CcSEcCtD
